Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07084753Not yet recruiting
Randomised, open-label trial of levobupivacaine in postoperative pain (3 arms). Primary endpoints: Postoperative pain levels measured by the 0-10 Numerical rating scale (NRS) at 10 days and Opioid analgesic consumption (Morphine milligram equivalents- MME) at 10 days. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07084753.